|3Aug 27, 6:45 PM ET

Rosy Shine Ltd 3

3 · BioNano Genomics, Inc · Filed Aug 27, 2018

Insider Transaction Report

Form 3
Period: 2018-08-23
Holdings
  • Common Stock

    1,134,000
Footnotes (1)
  • [F1]Represents the conversion of an outstanding convertible promissory note in the principal amount of $5,000,000, plus $209,315.07 accrued interest, into shares of the Issuer's common stock upon closing of the Issuer's initial public offering at a conversion price of $6.125 per share.

Documents

2 files
  • 3
    doc3.xmlPrimary

    FORM 3 SUBMISSION

  • EX-24.3_807184

    POA DOCUMENT